These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35792393)

  • 41. The variants question: What is the problem?
    Zella D; Giovanetti M; Benedetti F; Unali F; Spoto S; Guarino M; Angeletti S; Ciccozzi M
    J Med Virol; 2021 Dec; 93(12):6479-6485. PubMed ID: 34255352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
    Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.
    Sun C; Xie C; Bu GL; Zhong LY; Zeng MS
    Signal Transduct Target Ther; 2022 Jun; 7(1):202. PubMed ID: 35764603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review.
    Bhat EA; Khan J; Sajjad N; Ali A; Aldakeel FM; Mateen A; Alqahtani MS; Syed R
    Int Immunopharmacol; 2021 Jun; 95():107493. PubMed ID: 33721758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
    Xia S; Wang L; Zhu Y; Lu L; Jiang S
    Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models.
    Kim YI; Casel MAB; Choi YK
    J Microbiol; 2022 Mar; 60(3):255-267. PubMed ID: 35235177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
    Mohammed RN; Tamjidifar R; Rahman HS; Adili A; Ghoreishizadeh S; Saeedi H; Thangavelu L; Shomali N; Aslaminabad R; Marofi F; Tahavvori M; Danshina S; Akbari M; Ercan G
    Cell Commun Signal; 2022 Jun; 20(1):79. PubMed ID: 35655192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2.
    Negi K; Agarwal M; Pahuja I; Bhardwaj B; Rawat M; Bhaskar A; Dwivedi VP
    Oxf Open Immunol; 2023; 4(1):iqad001. PubMed ID: 37051070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion.
    Zhan Y; Ye L; Ouyang Q; Yin J; Cui J; Liu K; Guo C; Zhang H; Zhai J; Zheng C; Guo A; Sun B
    J Med Virol; 2023 Sep; 95(9):e29113. PubMed ID: 37750416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.
    Abdalla AE; Xie J; Junaid K; Younas S; Elsaman T; Abosalif KOA; Alameen AAM; Mahjoob MO; Elamir MYM; Ejaz H
    Bosn J Basic Med Sci; 2021 Oct; 21(5):515-527. PubMed ID: 33714258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.
    Coveney C; Tellier M; Lu F; Maleki-Toyserkani S; Jones R; Bart VMT; Pring E; Alrubayyi A; Richter FC; Scourfield DO; Rehwinkel J; Rodrigues PRS; Davies LC; Gea-Mallorquí E;
    Oxf Open Immunol; 2020; 1(1):iqaa004. PubMed ID: 34192267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.
    Alturaiki W; Mubarak A; Al Jurayyan A; Hemida MG
    Hum Vaccin Immunother; 2021 Oct; 17(10):3297-3309. PubMed ID: 34114940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Mechanisms and Potential Antiviral Strategies of Liquid-Liquid Phase Separation during Coronavirus Infection.
    Wang Y; Zhou L; Wu X; Yang S; Wang X; Shen Q; Liu Y; Zhang W; Ji L
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunobiology and immunotherapy of COVID-19: A clinically updated overview.
    Esmaeilzadeh A; Elahi R
    J Cell Physiol; 2021 Apr; 236(4):2519-2543. PubMed ID: 33022076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
    Sievers BL; Cheng MTK; Csiba K; Meng B; Gupta RK
    Cell Mol Immunol; 2024 Feb; 21(2):171-183. PubMed ID: 37985854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.